These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Postoperative Nomogram for Predicting Cancer-Specific Mortality in Medullary Thyroid Cancer. Ho AS, Wang L, Palmer FL, Yu C, Toset A, Patel S, Kattan MW, Tuttle RM, Ganly I. Ann Surg Oncol; 2015 Aug; 22(8):2700-6. PubMed ID: 25366585 [Abstract] [Full Text] [Related]
3. Postoperative nomograms predictive of survival after surgical management of malignant tumors of the major salivary glands. Ali S, Palmer FL, Yu C, DiLorenzo M, Shah JP, Kattan MW, Patel SG, Ganly I. Ann Surg Oncol; 2014 Feb; 21(2):637-42. PubMed ID: 24132626 [Abstract] [Full Text] [Related]
5. External validation of preoperative and postoperative nomograms for prediction of cancer-specific survival, overall survival and recurrence after robot-assisted radical cystectomy for urothelial carcinoma of the bladder. Al-Daghmin A, English S, Kauffman EC, Din R, Khan A, Syed JR, Sztorc J, Mehedint D, Sharif M, Shi Y, Wilding G, Guru KA. BJU Int; 2014 Aug; 114(2):253-60. PubMed ID: 24119175 [Abstract] [Full Text] [Related]
11. Nomograms to Predict Recurrence-Free and Overall Survival After Curative Resection of Adrenocortical Carcinoma. Kim Y, Margonis GA, Prescott JD, Tran TB, Postlewait LM, Maithel SK, Wang TS, Evans DB, Hatzaras I, Shenoy R, Phay JE, Keplinger K, Fields RC, Jin LX, Weber SM, Salem AI, Sicklick JK, Gad S, Yopp AC, Mansour JC, Duh QY, Seiser N, Solorzano CC, Kiernan CM, Votanopoulos KI, Levine EA, Poultsides GA, Pawlik TM. JAMA Surg; 2016 Apr 15; 151(4):365-73. PubMed ID: 26676603 [Abstract] [Full Text] [Related]
12. Prognostic nomograms for patients with resectable hepatocelluar carcinoma incorporating systemic inflammation and tumor characteristics. Shen J, He L, Li C, Wen T, Chen W, Lu C, Yan L, Li B, Yang J. Oncotarget; 2016 Dec 06; 7(49):80783-80793. PubMed ID: 27811374 [Abstract] [Full Text] [Related]
14. Salivary gland carcinoma: independent prognostic factors for locoregional control, distant metastases, and overall survival: results of the Dutch head and neck oncology cooperative group. Terhaard CH, Lubsen H, Van der Tweel I, Hilgers FJ, Eijkenboom WM, Marres HA, Tjho-Heslinga RE, de Jong JM, Roodenburg JL, Dutch Head and Neck Oncology Cooperative Group. Head Neck; 2004 Aug 06; 26(8):681-92; discussion 692-3. PubMed ID: 15287035 [Abstract] [Full Text] [Related]
15. Cavernous sinus involvement is not a risk factor for the primary tumor site treatment outcome of Sinonasal adenoid cystic carcinoma. Lee YC, Lee TJ, Tsang NM, Huang Y, Hsu CL, Hsin LJ, Lee YH, Chang KP. J Otolaryngol Head Neck Surg; 2018 Feb 05; 47(1):12. PubMed ID: 29402308 [Abstract] [Full Text] [Related]
16. Treatment of maxillary sinus carcinoma: a comparison of the 1997 and 1977 American Joint Committee on cancer staging systems. Le QT, Fu KK, Kaplan M, Terris DJ, Fee WE, Goffinet DR. Cancer; 1999 Nov 01; 86(9):1700-11. PubMed ID: 10547542 [Abstract] [Full Text] [Related]
17. Higher positive lymph node ratio indicates poorer distant metastasis-free survival in adenoid cystic carcinoma patients with nodal involvement. Liu Z, Fang Z, Dai T, Zhang C, Sun J, He Y. J Craniomaxillofac Surg; 2015 Jul 01; 43(6):751-7. PubMed ID: 25958766 [Abstract] [Full Text] [Related]
20. Similar outcomes between adenoid cystic carcinoma of the breast and invasive ductal carcinoma: a population-based study from the SEER 18 database. Chen QX, Li JJ, Wang XX, Lin PY, Zhang J, Song CG, Shao ZM. Oncotarget; 2017 Jan 24; 8(4):6206-6215. PubMed ID: 28008158 [Abstract] [Full Text] [Related] Page: [Next] [New Search]